Glenmark Pharmaceuticals Ltd has clarified in relation to an article on Glenmark published in today's edition of Indian Express.
In response to an article published by the Indian Express in its today's edition with respect to Glenmark's Ankleshwar plant receiving observations from the USFDA during its inspection in December, 2016. In this regard, Glenmark would like to state that its Ankleshwar plant has received the EIR (Establishment Inspection Report) yesterday. The EIR is issued by the FDA only if it finds the facility to be deemed acceptable.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.900.8 as compared to the previous close of Rs. 890.9. The total number of shares traded during the day was 63311 in over 2934 trades.
The stock hit an intraday high of Rs. 929.9 and intraday low of 895.1. The net turnover during the day was Rs. 57441939.